Concepedia

Dora Hammerl

DH

Statistics

Publications

4

Citations

328

H-Index

4

Active since

2018

Affiliations

Erasmus MC Cancer Institute(Current)

Dora Hammerl is an author at Erasmus MC Cancer Institute specializing in t cell immunity, oncology, and tumor immunity.

ORCID

Top concepts

Publications per year

2018–2021

4

Publications

4

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

Dora Hammerl, John W.M. Martens, Mieke Timmermans et al. · Nature Communications · 2021 · 229 citations · Full text

, , +20

Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes

Dora Hammerl, Maarten P.G. Massink, Marcel Smid et al. · Clinical Cancer Research · 2019 · 49 citations · Full text

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer

Katharina Uhr, Anieta M. Sieuwerts, Vanja de Weerd et al. · Scientific Reports · 2018 · 35 citations · Full text

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma

Pim Mutsaers, Hayri E. Balcıoğlu, Rowan Kuiper et al. · Cancers · 2021 · 15 citations · Full text

1–4 of 4